ArticleFrontiers in plant science2025
Biological mechanisms of sodium nitroprusside in enhancing quality of Radix Paeoniae Rubra and Radix Paeoniae Alba.
Article in Frontiers in plant science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Both Paeoniae Radix Alba (RAP) and Paeoniae Radix Rubra (RRP) are important botanical drugs used in Asian countries. Although they are both derived from the roots of Methods: Fresh roots of Results: In the fresh roots of RRP-germplasm treated with 0.5 mmol/L SNP, the secondary metabolites paeoniflorin, albiflorin, oxypaeoniflorin, gallic acid, catechin, and paeonol were elevated by 19.1%, 205.4%, 115.4%, 19.9%, 201.0%, and 585.2%, respectively, and in the fresh roots of RAP-germplasm treated with 2.5 mmol/L SNP, the major secondary metabolites paeoniflorin, albiflorin, oxypaeoniflorin, gallic acid, catechin, and benzoic acid showed increases of 25.4%, 70.4%, 95.1%, 6.7%, 86.5%, and 33.6%, respectively. Moreover, experiments involving combined treatment with SNP and ROS scavengers demonstrated that ROS act as the key mediator linking exogenous NO to the secondary metabolism of Discussion: Combined with the above findings of SNP promoting secondary metabolite synthesis, this study confirms that exogenous NO can improve the quality of cultivated RAP and RRP via ROS-mediated secondary metabolism, and clarifies the NO-ROS-secondary metabolism regulatory axis, offering insights for other medicinal plants' quality improvement.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.